{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:02:45Z","timestamp":1791406965365,"version":"4.3.3"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T00:00:00Z","timestamp":1468195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mesenchymal stem cells (MSCs) are currently the most established cells for skeletal tissue engineering and regeneration; however, their availability and capability of self-renewal are limited. Recent discoveries of somatic cell reprogramming may be used to overcome these challenges. We hypothesized that induced pluripotent stem cells (iPSCs) that were differentiated into MSCs could be used for bone regeneration. Short-term exposure of embryoid bodies to transforming growth factor-\u03b2 was used to direct iPSCs toward MSC differentiation. During this process, two types of iPSC-derived MSCs (iMSCs) were identified: early (aiMSCs) and late (tiMSCs) outgrowing cells. The transition of iPSCs toward MSCs was documented using MSC marker flow cytometry. Both types of iMSCs differentiated in vitro in response to osteogenic or adipogenic supplements. The results of quantitative assays showed that both cell types retained their multidifferentiation potential, although aiMSCs demonstrated higher osteogenic potential than tiMSCs and bone marrow-derived MSCs (BM-MSCs). Ectopic injections of BMP6-overexpressing tiMSCs produced no or limited bone formation, whereas similar injections of BMP6-overexpressing aiMSCs resulted in substantial bone formation. Upon orthotopic injection into radial defects, all three cell types regenerated bone and contributed to defect repair. In conclusion, MSCs can be derived from iPSCs and exhibit self-renewal without tumorigenic ability. Compared with BM-MSCs, aiMSCs acquire more of a stem cell phenotype, whereas tiMSCs acquire more of a differentiated osteoblast phenotype, which aids bone regeneration but does not allow the cells to induce ectopic bone formation (even when triggered by bone morphogenetic proteins), unless in an orthotopic site of bone fracture.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Significance<\/jats:title>\n                    <jats:p>Mesenchymal stem cells (MSCs) are currently the most established cells for skeletal tissue engineering and regeneration of various skeletal conditions; however, availability of autologous MSCs is very limited. This study demonstrates a new method to differentiate human fibroblast-derived induced pluripotent stem cells (iPSCs) to cells with MSC properties, which we comprehensively characterized including differentiation potential and transcriptomic analysis. We showed that these iPS-derived MSCs are able to regenerate nonunion bone defects in mice more efficiently than bone marrow-derived human MSCs when overexpressing BMP6 using a nonviral transfection method.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5966\/sctm.2015-0311","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T03:22:21Z","timestamp":1468293741000},"page":"1447-1460","source":"Crossref","is-referenced-by-count":129,"title":["Human Induced Pluripotent Stem Cells Differentiate Into Functional Mesenchymal Stem Cells and Repair Bone Defects"],"prefix":"10.1093","volume":"5","author":[{"given":"Dmitriy","family":"Sheyn","sequence":"first","affiliation":[{"name":"Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran","family":"Ben-David","sequence":"additional","affiliation":[{"name":"Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Skeletal Biotech Laboratory, Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"De Mel","sequence":"additional","affiliation":[{"name":"Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Bez","sequence":"additional","affiliation":[{"name":"Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Skeletal Biotech Laboratory, Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Ornelas","sequence":"additional","affiliation":[{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"iPSC Core Facility, The David and Janet Polak Stem Cell Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Sahabian","sequence":"additional","affiliation":[{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"iPSC Core Facility, The David and Janet Polak Stem Cell Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv","family":"Sareen","sequence":"additional","affiliation":[{"name":"Skeletal Biotech Laboratory, Hebrew University of Jerusalem, Jerusalem, Israel"},{"name":"iPSC Core Facility, The David and Janet Polak Stem Cell Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Da","sequence":"additional","affiliation":[{"name":"Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gadi","family":"Pelled","sequence":"additional","affiliation":[{"name":"Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Skeletal Biotech Laboratory, Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Tawackoli","sequence":"additional","affiliation":[{"name":"Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiu","family":"Liu","sequence":"additional","affiliation":[{"name":"Biostatistics and Bioinformatics Core, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Gazit","sequence":"additional","affiliation":[{"name":"Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Skeletal Biotech Laboratory, Hebrew University of Jerusalem, Jerusalem, Israel"},{"name":"Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulma","family":"Gazit","sequence":"additional","affiliation":[{"name":"Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA"},{"name":"Skeletal Biotech Laboratory, Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,7,11]]},"reference":[{"key":"2021122705124564300_R1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood.V93.3.826","article-title":"HCA, an immunoglobulin-like adhesion molecule present on the earliest human hematopoietic precursor cells, is also expressed by stromal cells in blood-forming tissues","volume":"93","author":"Cort\u00e9s","year":"1999","journal-title":"Blood"},{"key":"2021122705124564300_R2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1097-0177(199906)215:2<139::AID-DVDY6>3.0.CO;2-#","article-title":"Detailed characterization of the human aorta-gonad-mesonephros region reveals morphological polarity resembling a hematopoietic stromal layer","volume":"215","author":"Marshall","year":"1999","journal-title":"Dev Dyn"},{"key":"2021122705124564300_R3","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1182\/blood.V98.8.2396","article-title":"Identification of mesenchymal stem\/progenitor cells in human first-trimester fetal blood, liver, and bone marrow","volume":"98","author":"Campagnoli","year":"2001","journal-title":"Blood"},{"key":"2021122705124564300_R4","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Mol Biol Cell"},{"key":"2021122705124564300_R5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1634\/stemcells.19-3-180","article-title":"Bone marrow stromal stem cells: Nature, biology, and potential applications","volume":"19","author":"Bianco","year":"2001","journal-title":"Stem Cells"},{"key":"2021122705124564300_R6","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.bone.2006.04.020","article-title":"Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair","volume":"39","author":"Krampera","year":"2006","journal-title":"Bone"},{"key":"2021122705124564300_R7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/1521-2254(200105\/06)3:3<240::AID-JGM181>3.0.CO;2-A","article-title":"Engineered human mesenchymal stem cells: A novel platform for skeletal cell mediated gene therapy","volume":"3","author":"Turgeman","year":"2001","journal-title":"J Gene Med"},{"key":"2021122705124564300_R8","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1021\/mp200226c","article-title":"Gene-modified adult stem cells regenerate vertebral bone defect in a rat model","volume":"8","author":"Sheyn","year":"2011","journal-title":"Mol Pharm"},{"key":"2021122705124564300_R9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.gt.3303070","article-title":"Ultrasound-based nonviral gene delivery induces bone formation in vivo","volume":"15","author":"Sheyn","year":"2008","journal-title":"Gene Ther"},{"key":"2021122705124564300_R10","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1634\/stemcells.2005-0546","article-title":"Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells","volume":"24","author":"Aslan","year":"2006","journal-title":"Stem Cells"},{"key":"2021122705124564300_R11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1089\/ten.2007.0096","article-title":"Review: Gene- and stem cell-based therapeutics for bone regeneration and repair","volume":"13","author":"Kimelman","year":"2007","journal-title":"Tissue Eng"},{"key":"2021122705124564300_R12","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.10-161497","article-title":"Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix","volume":"25","author":"Sun","year":"2011","journal-title":"FASEB J"},{"key":"2021122705124564300_R13","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1038\/srep07144","article-title":"Aging disrupts cell subpopulation dynamics and diminishes the function of mesenchymal stem cells","volume":"4","author":"Duscher","year":"2014","journal-title":"Sci Rep"},{"key":"2021122705124564300_R14","doi-asserted-by":"crossref","first-page":"e115963","DOI":"10.1371\/journal.pone.0115963","article-title":"Impact of aging on the regenerative properties of bone marrow-, muscle-, and adipose-derived mesenchymal stem\/stromal cells","volume":"9","author":"Beane","year":"2014","journal-title":"PLoS One"},{"key":"2021122705124564300_R15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/14653240903079393","article-title":"Human adipose-derived stem cells isolated from young and elderly women: Their differentiation potential and scaffold interaction during in vitro osteoblastic differentiation","volume":"11","author":"de Girolamo","year":"2009","journal-title":"Cytotherapy"},{"key":"2021122705124564300_R16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bone.2014.02.002","article-title":"Aging periosteal progenitor cells have reduced regenerative responsiveness to bone injury and to the anabolic actions of PTH 1-34 treatment","volume":"62","author":"Yukata","year":"2014","journal-title":"Bone"},{"key":"2021122705124564300_R17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/ncomms1611","article-title":"Muscle-derived stem\/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model","volume":"3","author":"Lavasani","year":"2012","journal-title":"Nat Commun"},{"key":"2021122705124564300_R18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"2021122705124564300_R19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2184.2011.00744.x","article-title":"Mesenchymal differentiation propensity of a human embryonic stem cell line","volume":"44","author":"Pringle","year":"2011","journal-title":"Cell Prolif"},{"key":"2021122705124564300_R20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3109\/14653240903067299","article-title":"Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model","volume":"11","author":"Laurila","year":"2009","journal-title":"Cytotherapy"},{"key":"2021122705124564300_R21","doi-asserted-by":"crossref","first-page":"I166","DOI":"10.1161\/CIRCULATIONAHA.104.525824","article-title":"Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium","volume":"112","author":"Swijnenburg","year":"2005","journal-title":"Circulation"},{"key":"2021122705124564300_R22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.stem.2008.05.005","article-title":"Human stem cell ethics: Beyond the embryo","volume":"2","author":"Sugarman","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2021122705124564300_R23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.febslet.2009.02.031","article-title":"Adipogenic differentiation of human induced pluripotent stem cells: Comparison with that of human embryonic stem cells","volume":"583","author":"Taura","year":"2009","journal-title":"FEBS Lett"},{"key":"2021122705124564300_R24","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1096\/fj.09-137174","article-title":"Generation of skeletal muscle stem\/progenitor cells from murine induced pluripotent stem cells","volume":"24","author":"Mizuno","year":"2010","journal-title":"FASEB J"},{"key":"2021122705124564300_R25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/mt.2009.274","article-title":"Complete genetic correction of iPS cells from Duchenne muscular dystrophy","volume":"18","author":"Kazuki","year":"2010","journal-title":"Mol Ther"},{"key":"2021122705124564300_R26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.109.898312","article-title":"Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice","volume":"121","author":"Lian","year":"2010","journal-title":"Circulation"},{"key":"2021122705124564300_R27","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1073\/pnas.0905729106","article-title":"Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue","volume":"107","author":"Song","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122705124564300_R28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.addr.2010.01.002","article-title":"Genetically modified cells in regenerative medicine and tissue engineering","volume":"62","author":"Sheyn","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"2021122705124564300_R29","doi-asserted-by":"crossref","first-page":"20379","DOI":"10.1073\/pnas.1218052109","article-title":"In vivo directed differentiation of pluripotent stem cells for skeletal regeneration","volume":"109","author":"Levi","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122705124564300_R30","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/stem.37","article-title":"Deconstructing stem cell tumorigenicity: A roadmap to safe regenerative medicine","volume":"27","author":"Knoepfler","year":"2009","journal-title":"Stem Cells"},{"key":"2021122705124564300_R31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGFbeta","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"2021122705124564300_R32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semcdb.2014.05.017","article-title":"Roles of TGF-\u03b2 family signals in the fate determination of pluripotent stem cells","volume":"32","author":"Itoh","year":"2014","journal-title":"Semin Cell Dev Biol"},{"key":"2021122705124564300_R33","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/emboj.2011.2","article-title":"Small RNA-mediated regulation of iPS cell generation","volume":"30","author":"Li","year":"2011","journal-title":"EMBO J"},{"key":"2021122705124564300_R34","doi-asserted-by":"crossref","first-page":"e87151","DOI":"10.1371\/journal.pone.0087151","article-title":"Generation of human induced pluripotent stem (Ips) cells in serum- and feeder-free defined culture and TGF-\u03921 regulation of pluripotency","volume":"9","author":"Yamasaki","year":"2014","journal-title":"PLoS One"},{"key":"2021122705124564300_R35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5966\/sctm.2011-0022","article-title":"Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem\/stromal cells","volume":"1","author":"Chen","year":"2012","journal-title":"Stem Cells Translational Medicine"},{"key":"2021122705124564300_R36","doi-asserted-by":"crossref","first-page":"140201","DOI":"10.1098\/rsob.140201","article-title":"Promoting effect of 1,25(OH)2 vitamin D3 in osteogenic differentiation from induced pluripotent stem cells to osteocyte-like cells","volume":"5","author":"Kato","year":"2015","journal-title":"Open Biol"},{"key":"2021122705124564300_R37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jcb.22440","article-title":"Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage","volume":"109","author":"Li","year":"2010","journal-title":"J Cell Biochem"},{"key":"2021122705124564300_R38","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1445-2197.2007.04175.x","article-title":"Bone morphogenetic proteins in clinical applications","volume":"77","author":"Gautschi","year":"2007","journal-title":"ANZ J Surg"},{"key":"2021122705124564300_R39","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/sj.gt.3302298","article-title":"Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery","volume":"11","author":"Kang","year":"2004","journal-title":"Gene Ther"},{"key":"2021122705124564300_R40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mt.2010.190","article-title":"Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair","volume":"19","author":"Kimelman-Bleich","year":"2011","journal-title":"Mol Ther"},{"key":"2021122705124564300_R41","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1089\/ten.tea.2009.0786","article-title":"Genetically modified mesenchymal stem cells induce mechanically stable posterior spine fusion","volume":"16","author":"Sheyn","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"2021122705124564300_R42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/08977190802707324","article-title":"A comparative study on BMP-induced osteoclastogenesis and osteoblastogenesis in primary cultures of adult rat bone marrow cells","volume":"27","author":"Paul","year":"2009","journal-title":"Growth Factors"},{"key":"2021122705124564300_R43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/jor.20359","article-title":"Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells","volume":"25","author":"Luu","year":"2007","journal-title":"J Orthop Res"},{"key":"2021122705124564300_R44","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/jor.20068","article-title":"Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6","volume":"24","author":"Zachos","year":"2006","journal-title":"J Orthop Res"},{"key":"2021122705124564300_R45","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/jor.21126","article-title":"Osteoblastic differentiation of human and equine adult bone marrow-derived mesenchymal stem cells when BMP-2 or BMP-7 homodimer genetic modification is compared to BMP-2\/7 heterodimer genetic modification in the presence and absence of dexamethasone","volume":"28","author":"Carpenter","year":"2010","journal-title":"J Orthop Res"},{"key":"2021122705124564300_R46","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.gt.3302075","article-title":"Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat","volume":"10","author":"Li","year":"2003","journal-title":"Gene Ther"},{"key":"2021122705124564300_R47","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2106\/00004623-200308000-00017","article-title":"Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs)","volume":"85-A","author":"Cheng","year":"2003","journal-title":"J Bone Joint Surg Am"},{"key":"2021122705124564300_R48","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/ten.2006.12.877","article-title":"Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration","volume":"12","author":"Aslan","year":"2006","journal-title":"Tissue Eng"},{"key":"2021122705124564300_R49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3171\/spi.2005.3.1.0047","article-title":"Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein-2","volume":"3","author":"Hasharoni","year":"2005","journal-title":"J Neurosurg Spine"},{"key":"2021122705124564300_R50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/mthe.2001.0291","article-title":"Exogenously regulated stem cell-mediated gene therapy for bone regeneration","volume":"3","author":"Moutsatsos","year":"2001","journal-title":"Mol Ther"},{"key":"2021122705124564300_R51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/gt.2012.45","article-title":"BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells","volume":"20","author":"Mizrahi","year":"2013","journal-title":"Gene Ther"},{"key":"2021122705124564300_R52","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1634\/stemcells.2007-0858","article-title":"Nonvirally engineered porcine adipose tissue-derived stem cells: Use in posterior spinal fusion","volume":"26","author":"Sheyn","year":"2008","journal-title":"Stem Cells"},{"key":"2021122705124564300_R53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","article-title":"A more efficient method to generate integration-free human iPS cells","volume":"8","author":"Okita","year":"2011","journal-title":"Nat Methods"},{"key":"2021122705124564300_R54","doi-asserted-by":"crossref","first-page":"208ra149","DOI":"10.1126\/scitranslmed.3007529","article-title":"Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion","volume":"5","author":"Sareen","year":"2013","journal-title":"Sci Transl Med"},{"key":"2021122705124564300_R55","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1002\/cne.23578","article-title":"Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord","volume":"522","author":"Sareen","year":"2014","journal-title":"J Comp Neurol"},{"key":"2021122705124564300_R56","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.5966\/sctm.2014-0121","article-title":"Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines","volume":"3","author":"Barrett","year":"2014","journal-title":"Stem Cells Translational Medicine"},{"key":"2021122705124564300_R57","doi-asserted-by":"crossref","first-page":"e37342","DOI":"10.1371\/journal.pone.0037342","article-title":"Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells","volume":"7","author":"Kuroda","year":"2012","journal-title":"PLoS One"},{"key":"2021122705124564300_R58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"2021122705124564300_R59","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.spinee.2013.02.065","article-title":"Nucleus pulposus degeneration alters properties of resident progenitor cells","volume":"13","author":"Mizrahi","year":"2013","journal-title":"Spine J"},{"key":"2021122705124564300_R60","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/rme.13.25","article-title":"Transient overexpression of Ppar\u03b32 and C\/ebp\u03b1 in mesenchymal stem cells induces brown adipose tissue formation","volume":"8","author":"Sheyn","year":"2013","journal-title":"Regen Med"},{"key":"2021122705124564300_R61","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1097\/01.brs.0000146462.92171.7f","article-title":"Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: Implications for cell-based transplantation therapy","volume":"29","author":"Risbud","year":"2004","journal-title":"Spine"},{"key":"2021122705124564300_R62","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1097\/BRS.0b013e318158dea6","article-title":"Evidence for skeletal progenitor cells in the degenerate human intervertebral disc","volume":"32","author":"Risbud","year":"2007","journal-title":"Spine"},{"key":"2021122705124564300_R63","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1089\/ten.tea.2007.0241","article-title":"Nanobiomechanics of repair bone regenerated by genetically modified mesenchymal stem cells","volume":"14","author":"Tai","year":"2008","journal-title":"Tissue Eng Part A"},{"key":"2021122705124564300_R64","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nprot.2010.180","article-title":"Microcomputed tomography-based structural analysis of various bone tissue regeneration models","volume":"6","author":"Kallai","year":"2011","journal-title":"Nat Protoc"},{"key":"2021122705124564300_R65","first-page":"61","article-title":"Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture","volume":"40","author":"M\u00fcller","year":"1997","journal-title":"Stud Health Technol Inform"},{"key":"2021122705124564300_R66","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1359\/jbmr.1999.14.7.1167","article-title":"Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus","volume":"14","author":"Hildebrand","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2021122705124564300_R67","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1016\/j.biomaterials.2009.05.027","article-title":"The use of a synthetic oxygen carrier-enriched hydrogel to enhance mesenchymal stem cell-based bone formation in vivo","volume":"30","author":"Kimelman-Bleich","year":"2009","journal-title":"Biomaterials"},{"key":"2021122705124564300_R68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"2021122705124564300_R69","doi-asserted-by":"crossref","first-page":"e100285","DOI":"10.1371\/journal.pone.0100285","article-title":"Therapeutic effect of TSG-6 engineered iPSC-derived MSCs on experimental periodontitis in rats: A pilot study","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"2021122705124564300_R70","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.stemcr.2014.07.003","article-title":"Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells","volume":"3","author":"Frobel","year":"2014","journal-title":"Stem Cell Rep"},{"key":"2021122705124564300_R71","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1089\/scd.2013.0111","article-title":"Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines","volume":"23","author":"Hynes","year":"2014","journal-title":"Stem Cells Dev"},{"key":"2021122705124564300_R72","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00395-012-0301-5","article-title":"Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart","volume":"107","author":"Buccini","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"2021122705124564300_R73","doi-asserted-by":"crossref","first-page":"e33225","DOI":"10.1371\/journal.pone.0033225","article-title":"One-step derivation of mesenchymal stem cell (MSC)-like cells from human pluripotent stem cells on a fibrillar collagen coating","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"2021122705124564300_R74","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/stem.1084","article-title":"Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates","volume":"30","author":"Villa-Diaz","year":"2012","journal-title":"Stem Cells"},{"key":"2021122705124564300_R75","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1182\/blood-2010-12-325324","article-title":"Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery","volume":"118","author":"Giuliani","year":"2011","journal-title":"Blood"},{"key":"2021122705124564300_R76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/stem.2224","article-title":"Mesenchymal stromal cells for treatment of acute steroid-refractory GvHD: Clinical responses and long-term outcome","volume":"34","author":"von Dalowski","year":"2016","journal-title":"Stem Cells"},{"issue":"(Nov):","key":"2021122705124564300_R77","first-page":"27","article-title":"Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies","author":"Ye","year":"2015","journal-title":"Cancer Lett"},{"key":"2021122705124564300_R78","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cytogfr.2015.11.009","article-title":"Mechanisms of action of bone morphogenetic proteins in cancer","volume":"27","author":"Davis","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"2021122705124564300_R79","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbrc.2015.08.124","article-title":"Secreted phosphoprotein 24 kD (Spp24) inhibits growth of human pancreatic cancer cells caused by BMP-2","volume":"466","author":"Li","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"2021122705124564300_R80","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1038\/sj.onc.1204962","article-title":"Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos\/jun family members","volume":"20","author":"Wach","year":"2001","journal-title":"Oncogene"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0311","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2015-0311","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/5\/11\/1447\/41870588\/stcltm_5_11_1447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/5\/11\/1447\/41870588\/stcltm_5_11_1447.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T21:50:41Z","timestamp":1642542641000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/5\/11\/1447-1460\/6397642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,11]]},"references-count":80,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,7,11]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2015-0311","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726500934.793529431","asserted-by":"object"}]},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,11,1]]},"published":{"date-parts":[[2016,7,11]]}}}